Methoxamine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Methoxamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(One intermediate revision by one other user not shown)
Line 25: Line 25:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
__NOTOC__
{{SI}}
{{CMG}}
{{CMG}}


{{Editor Join}}
==Overview==
 
'''Methoxamine''' is an α<sub>1</sub>-[[adrenergic agonist|adrenergic receptor agonist]],<ref>{{cite book |last1=Pazdernik |first1=Thomas L. |authorlink1= |last2=Kerecsen |first2=Laszlo |editor1-first=Edward F. |editor1-last=Goljan |editor1-link= |others= |title=Pharmacology |trans_title= |url= |format=Paperback |accessdate=17 Apr 2010 |type= |edition=Second |series=Rapid Review |volume= |date= |year=2007 |month= |origyear=2003|publisher=Mosby-Elsevier |location=Philadelphia, PA |isbn=978-0-323-04550-6 |oclc= |doi= |id= |page=39 |pages= |trans_chapter= |chapter=5 |chapterurl= |quote= |ref= |bibcode= |laysummary= |laydate= |separator= |postscript= |lastauthoramp=}}</ref> similar in structure to [[phenylephrine]] and [[2,5-DMA]]. It was developed by Burroughs-Wellcome in the 1940s.<ref>US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE</ref> The drug induces vasoconstriction of skin and [[splanchnic]] blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex [[bradycardia]] via the [[baroreceptors]].


==Overview==
== See Also ==
'''Methoxamine''' is an α<sub>1</sub>-[[adrenergic agonist|adrenergic receptor agonist]], similar to [[phenylephrine]]. It induces vasoconstriction of skin and [[splanchnic]] blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex [[bradycardia]].
* [[Butaxamine]]
* [[Phenylephrine]]
* [[Synephrine]]


== References ==
{{Reflist|2}}


{{Stimulants}}
{{Cardiac stimulants excluding cardiac glycosides}}
{{Cardiac stimulants excluding cardiac glycosides}}
{{Phenethylamines}}


[[Category:Phenethylamines]]
[[Category:Amphetamines]]
[[Category:Drugs]]
[[Category:Cardiovascular Drugs]]
 
[[Category:Drug]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 00:05, 24 July 2014

Methoxamine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC11H17NO3
Molar mass211.258

WikiDoc Resources for Methoxamine

Articles

Most recent articles on Methoxamine

Most cited articles on Methoxamine

Review articles on Methoxamine

Articles on Methoxamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Methoxamine

Images of Methoxamine

Photos of Methoxamine

Podcasts & MP3s on Methoxamine

Videos on Methoxamine

Evidence Based Medicine

Cochrane Collaboration on Methoxamine

Bandolier on Methoxamine

TRIP on Methoxamine

Clinical Trials

Ongoing Trials on Methoxamine at Clinical Trials.gov

Trial results on Methoxamine

Clinical Trials on Methoxamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Methoxamine

NICE Guidance on Methoxamine

NHS PRODIGY Guidance

FDA on Methoxamine

CDC on Methoxamine

Books

Books on Methoxamine

News

Methoxamine in the news

Be alerted to news on Methoxamine

News trends on Methoxamine

Commentary

Blogs on Methoxamine

Definitions

Definitions of Methoxamine

Patient Resources / Community

Patient resources on Methoxamine

Discussion groups on Methoxamine

Patient Handouts on Methoxamine

Directions to Hospitals Treating Methoxamine

Risk calculators and risk factors for Methoxamine

Healthcare Provider Resources

Symptoms of Methoxamine

Causes & Risk Factors for Methoxamine

Diagnostic studies for Methoxamine

Treatment of Methoxamine

Continuing Medical Education (CME)

CME Programs on Methoxamine

International

Methoxamine en Espanol

Methoxamine en Francais

Business

Methoxamine in the Marketplace

Patents on Methoxamine

Experimental / Informatics

List of terms related to Methoxamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Methoxamine is an α1-adrenergic receptor agonist,[1] similar in structure to phenylephrine and 2,5-DMA. It was developed by Burroughs-Wellcome in the 1940s.[2] The drug induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.

See Also

References

  1. Pazdernik, Thomas L.; Kerecsen, Laszlo (2007) [2003]. "5". In Goljan, Edward F. Pharmacology (Paperback)|format= requires |url= (help). Rapid Review (Second ed.). Philadelphia, PA: Mosby-Elsevier. p. 39. ISBN 978-0-323-04550-6. |access-date= requires |url= (help)
  2. US Patent 2359707 - DIMETHOXYPHENYL beta-HYDROXY ISOPROPYLAMINE

Template:Stimulants Template:Cardiac stimulants excluding cardiac glycosides Template:Phenethylamines